These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 12818205
1. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies. Kipriyanov SM, Moldenhauer G, Braunagel M, Reusch U, Cochlovius B, Le Gall F, Kouprianova OA, Von der Lieth CW, Little M. J Mol Biol; 2003 Jun 27; 330(1):99-111. PubMed ID: 12818205 [Abstract] [Full Text] [Related]
2. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment. Asano R, Kudo T, Nishimura Y, Makabe K, Hayashi H, Suzuki M, Tsumoto K, Kumagai I. J Biochem; 2002 Dec 27; 132(6):903-9. PubMed ID: 12473192 [Abstract] [Full Text] [Related]
3. Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody. Le Gall F, Reusch U, Little M, Kipriyanov SM. Protein Eng Des Sel; 2004 Apr 27; 17(4):357-66. PubMed ID: 15126676 [Abstract] [Full Text] [Related]
4. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells. Reusch U, Duell J, Ellwanger K, Herbrecht C, Knackmuss SH, Fucek I, Eser M, McAleese F, Molkenthin V, Gall FL, Topp M, Little M, Zhukovsky EA. MAbs; 2015 Apr 27; 7(3):584-604. PubMed ID: 25875246 [Abstract] [Full Text] [Related]
5. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics. Kipriyanov SM, Moldenhauer G, Schuhmacher J, Cochlovius B, Von der Lieth CW, Matys ER, Little M. J Mol Biol; 1999 Oct 15; 293(1):41-56. PubMed ID: 10512714 [Abstract] [Full Text] [Related]
7. The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody. Lu D, Jimenez X, Witte L, Zhu Z. Biochem Biophys Res Commun; 2004 May 28; 318(2):507-13. PubMed ID: 15120630 [Abstract] [Full Text] [Related]
8. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics. Asano R, Shimomura I, Konno S, Ito A, Masakari Y, Orimo R, Taki S, Arai K, Ogata H, Okada M, Furumoto S, Onitsuka M, Omasa T, Hayashi H, Katayose Y, Unno M, Kudo T, Umetsu M, Kumagai I. MAbs; 2014 May 28; 6(5):1243-54. PubMed ID: 25517309 [Abstract] [Full Text] [Related]
10. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains. Kim YJ, Neelamegam R, Heo MA, Edwardraja S, Paik HJ, Lee SG. J Microbiol Biotechnol; 2008 Jun 28; 18(6):1186-90. PubMed ID: 18600066 [Abstract] [Full Text] [Related]